Health
New Drugs to Be Tested in Rwanda to Treat Ebola-Like Disease
- Rwanda facing outbreak of highly contagious Marburg virus
- There are no approved products for the Ebola-like infection
The drugs will be used under clinical trial conditions approved by the Rwandan regulator.
Photographer: Alex Kraus/BloombergThis article is for subscribers only.
Two experimental medicines for Marburg disease are set to tested in Rwanda, which is battling an outbreak of the deadly Ebola-like infection.
A vaccine from the Sabin Vaccine Institute and an experimental therapy from privately held biotech Mapp Biopharmaceutical Inc are being made available for use on the ground in Rwanda, according to a spokesperson from the US Administration for Strategic Preparedness and Response. The drugs will be used under clinical trial conditions approved by the Rwandan regulator, the spokesperson said.